BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 7229966)

  • 1. Theophylline absorption and disposition in rabbits: oral, intravenous, and concentration-dependent kinetic studies.
    El-Yazigi A; Sawchuk RJ
    J Pharm Sci; 1981 Apr; 70(4):452-6. PubMed ID: 7229966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative pharmacokinetics of theophylline and dyphylline following intravenous injection in rabbits.
    Ng PK; Locock RA
    Res Commun Chem Pathol Pharmacol; 1979 Dec; 26(3):509-24. PubMed ID: 523786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Theophylline: pharmacokinetics, metabolism and urinary excretion in dogs].
    Kuze T; Miyazaki H; Taneike T
    Nihon Yakurigaku Zasshi; 1988 May; 91(5):325-34. PubMed ID: 3410380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of intravenous theophylline.
    Chrzanowski FA; Niebergall PJ; Mayock RL; Taubin JM; Sugita ET
    Clin Pharmacol Ther; 1977 Aug; 22(2):188-95. PubMed ID: 884920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of theophylline and bioavailability of a sustained release theophylline preparation in patients with cystic fibrosis.
    Valet SB; Schwartz RH; Brooks JG
    Ann Allergy; 1983 Mar; 50(3):161-5. PubMed ID: 6829982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The rabbit as an experimental model for biopharmaceutical studies following rectal administration of theophylline.
    Van Aerde P; Moerman E; Van Severen R; Braeckman P
    Pharmazie; 1984 Mar; 39(3):171-2. PubMed ID: 6728890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic studies of theophylline in dogs.
    McKiernan BC; Neff-Davis CA; Koritz GD; Davis LE; Pheris DR
    J Vet Pharmacol Ther; 1981 Jun; 4(2):103-10. PubMed ID: 7349323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioavailability and pharmacokinetics of theophylline in plain uncoated and sustained-release dosage forms in relation to smoking habit. I. Single dose study.
    Horai Y; Ishizaki T; Sasaki T; Chiba K; Suganuma T; Echizen H; Ohnishi A
    Eur J Clin Pharmacol; 1983; 24(1):79-87. PubMed ID: 6832206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic properties of theophylline given intravenously and orally to ruminating calves.
    Langston VC; Koritz GD; Davis LE; Neff-Davis C
    Am J Vet Res; 1989 Apr; 50(4):493-7. PubMed ID: 2712416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic studies of theophylline in horses.
    Ingvast-Larsson C; Paalzow G; Paalzow L; Ottosson T; Lindholm A; Appelgren LE
    J Vet Pharmacol Ther; 1985 Mar; 8(1):76-81. PubMed ID: 3989903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailability and pharmacokinetics in man of orally administered theophylline.
    Nielsen-Kudsk F; Magnussen I; Jensen TS; Naeser K
    Acta Pharmacol Toxicol (Copenh); 1980 Mar; 46(3):205-12. PubMed ID: 7361576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of theophylline in beagle dogs and asthmatic patients after multiple oral doses of sustained-release theophylline tablet formulation.
    Nosaka H; Takagi K; Hasegawa T; Ogura Y; Mizukami Y; Satake T
    Int J Clin Pharmacol Ther Toxicol; 1986 Oct; 24(10):528-35. PubMed ID: 3781672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The beagle dog as an animal model for a bioavailability study of controlled-release theophylline under the influence of food.
    Shiu GK; LeMarchand A; Sager AO; Velagapudi RB; Skelly JP
    Pharm Res; 1989 Dec; 6(12):1039-42. PubMed ID: 2622858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and relative bioavailability of oral theophylline capsules.
    Lesko LJ; Canada AT; Eastwood G; Walker D; Brousseau DR
    J Pharm Sci; 1979 Nov; 68(11):1392-4. PubMed ID: 583162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of etofylline after intravenous and oral administration to humans.
    Zuidema J; Verhoeven J; Merkus FW
    Int J Clin Pharmacol Ther Toxicol; 1981 Jul; 19(7):310-3. PubMed ID: 7263108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of erythromycin on the absorption and disposition of kinetics of theophylline.
    Branigan TA; Robbins RA; Cady WJ; Nickols JG; Ueda CT
    Eur J Clin Pharmacol; 1981; 21(2):115-20. PubMed ID: 7341279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time-dependent absorption of theophylline in man.
    Watanabe H; Nakano S; Nagai K; Ogawa N
    J Clin Pharmacol; 1984; 24(11-12):509-14. PubMed ID: 6511990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition and clinical pharmacokinetics of theophylline after administration of a new sustained release tablet.
    Jonkman JH; Berg WC; de Vries K; de Zeeuw RA; Schoenmaker R; Grimberg N
    Eur J Clin Pharmacol; 1981; 21(1):39-44. PubMed ID: 7333345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theophylline bioavailability: a comparison of the oral absorption of a theophylline elixir and two combination theophylline tablets to intravenous aminophylline.
    Fixley M; Shen DD; Azarnoff DL
    Am Rev Respir Dis; 1977 Jun; 115(6):955-62. PubMed ID: 262107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Theophylline bioavailability in the dog.
    Tse FL; Szeto DW
    J Pharm Sci; 1982 Nov; 71(11):1301-3. PubMed ID: 7175732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.